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Abstract
Background: Studies have shown a consistent association between exposure to traffic-related air pollution and
adverse health effects. In particular, exposure can be high for cyclists who travel near roadways. The objective of
the current study was to examine the relationship between short-term exposure of near-road traffic emissions and
acute changes in lung function among individuals who frequently bike in the Sacramento and Davis areas in
California. Ultrafine particulate matter (UFPM) was used as a surrogate for near-roadway exposure in this study since
the main source of this pollutant is from motor vehicle exhaust.
Methods: Thirty-two bicyclists were recruited and completed two rides on separate days during the study period
of March-June, 2008. One ride was on a high traffic route paralleling a section of Interstate 80 (I-80)/Interstate
Business 80 (I-80B), and a second one was on a low traffic route, such as bike paths away from major highways. The
participant’s lung function was measured before and after each ride, and UFPM exposure was measured during the
rides using a condensation particle counter (CPC).
Results: In the final linear mixed-effect model using median UFPM concentrations as the main exposure, we
observed that lung function change (post–ride minus baseline measurements) shifted in the negative direction.
Lung function changed by 216 mL for FVC and 168 mL for FEV1, respectively, for an interquartile range (IQR: 12,225
to 36,833 number of particles/cm3) increase of UFPM concentration after adjusting for other covariates of age, sex,
wind direction, and day of the week.
Conclusions: This study found significant associations between increased levels of UFPM concentrations as a proxy
for near road traffic pollution, and decrements in lung function measurements. Our results are related to short-term
exposures, and the long-term health effects of cycling near heavy traffic require further research. Our study
suggests the need to reduce traffic pollution, particularly near roads. Cyclists should plan their route to reduce their
exposure where possible and further research on built environment designs may help urban planners to reduce the
potential health concerns of cyclists’ exposure to traffic-related air pollution.
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Background
Over the past few decades, a large body of scientific evi-
dence has shown a consistent association between expos-
ure to traffic-related air pollution and adverse health
effects including the exacerbation of asthma, and increased
respiratory symptoms, and cardiovascular diseases [1]. Al-
though traffic pollution is known to be associated with
health impacts, the source of these health impacts within
the mixture of near-roadway emissions has not been iden-
tified. Due to this uncertainty, a few components of traffic
air pollution have been utilized as surrogates to investigate
the health impacts of exposure including ultrafine particu-
late matter (UFPM) [2].
Although there are many localized sources of UFPM,
the main source of ambient UFPM is combustion from
motor vehicles, especially from diesel engines [3–7], and
near-roadway exposure dominates total daily exposure
to UFPM [8]. While there is no definitive consensus on the
best surrogate for traffic pollution, UFPM in the near road
environment is dominated by traffic emissions, and has
been used as a proxy for exposure to combustion-related
traffic emission from vehicles on the roadway [9–11].
Active transportation such as biking or walking has
been suggested as an important way of reducing vehicle
miles traveled (VMT) and emissions of traffic-related
pollutants, as well as providing increases in health bene-
fits from increased physical activity [12, 13]. However,
there is a concern that bicycle commuters might experi-
ence harmful effects from increased exposures to traffic-
related pollution due to their close proximity to vehicle
emissions and their increased ventilation rate [14].
Regarding the effects of UFPM from traffic emissions
near roadways on cyclists, limited information is available,
and the results are not consistent. While Vinzents et al. re-
ported an association between UFPM exposure among cy-
clists and oxidative DNA damage [11], other studies on
subclinical responses such as plasma IL-6, platelet func-
tion, or exhaled nitric oxide (NO) did not report any sig-
nificant changes in cyclist with UFPM exposure [15, 16].
Changes in airway resistance can be seen during pul-
monary function testing by measuring the total volume
of air an individual can exhale during a maximal breath
(FVC) as well as the volume of air that can be exhaled
during the first second of a maximal exhalation (FEV1).
During exercise, changes in the neural input to the lungs
allow the smooth muscle that controls airway diameter
to relax, effectively reducing the resistance along the air-
way, and this would be reflected in increases in lung
function measurements [17]. On the other hand, breath-
ing polluted air has been shown to activate airway sen-
sory nerves that cause air smooth muscle to contract,
which increases airway resistance. This increase in air-
way resistance can lead to reduction in lung function
measurements, which is also seen in many individuals
who suffer from obstructive airway diseases such as
asthma, chronic obstructive pulmonary disease (COPD),
and chronic bronchitis [18].
Zuurbier et al. found that decreased peak expiratory
flow (PEF), a measure of large airway function, was ob-
served among healthy nonsmoking adults two hours after
UFPM exposure from traffic, but not six hours after ex-
posure, and they did not find any difference in other lung
function measurements such as FVC and FEV1 [19]. A
Canadian study showed a significant association between
UFPM exposure and decreased heart rate variability
among cyclists with no changes in respiratory function
[20]. Also, a Dutch study observed negative trends in lung
function measurements such as FVC and FEV1 from ex-
posure to traffic air pollutants including UFPM six hours
after cycling, and positive associations when lung func-
tions were measured immediately after cycling, but none
of these were statistically significant [16]. In addition, one
U.S. study conducted in Berkeley, California reported no
corresponding changes in lung function after cycling on a
high- traffic route compared to a low-traffic route [21].
Similarly, an Australian study didn’t find significant differ-
ences in lung function or other related airway inflamma-
tion measures between higher and lower proximity to
motorized traffic, and they observed a significant decrease
in UFPM with decreased proximity to traffic compared to
increased proximity [22].
Given the limited number and inconsistent findings of
previous studies in California, we examined the relationship
between short-term exposure to UFPM, as a surrogate for
short-term exposure to near-road traffic emissions, and
acute changes in lung function among routine bicyclists in
the Sacramento/Davis region of California.
Methods
Study design
We recruited 32 bicyclists in the Sacramento area through
local bicycle organizations, office bicycle commuter
groups, and word-of-mouth. These subjects routinely used
cycling for active transportation and most rode bicycles to
work or to run errands on a regular basis, at least three
days a week. Subjects with preexisting conditions such as
eye, thoracic or abdominal surgery, a myocardial infarc-
tion, unstable angina pectoris, or a history of syncope as-
sociated with forced exhalation, were excluded unless they
obtained a medical release from their physician.
We asked participants to complete two rides on separ-
ate days during the study period of March, 2008 through
June, 2008. One ride was a high traffic route, directed
by researchers, paralleling a section of Interstate 80 (I-
80) /Interstate Business 80 (I-80B) from the point
where this highway crosses Mace Boulevard in Davis to
the area where the highway crosses 3rd street in Sacra-
mento, California. For approximately 12 km of the high
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traffic route the cyclists were within 10–20 m of I-80
(Rural Interstate), and for another 10 km of the route
the cyclists were within 400 m of the I-80/I-80B corri-
dor (Urban Interstate) on heavily used local thorough-
fares (Major Collectors).
The other routes were low traffic routes that included
minor local roads (Urban Minor Collectors), Rural Local
Roads, and/or bike paths away from major highways. On
the low traffic route participants rode at a speed similar
to that ridden on the high traffic route. High traffic routes
had over 100,000 vehicles per day on average (annual
average daily traffic) [23].
The high traffic route, assigned by researchers, was
mostly uniform across subjects and took place from home
to workplace which included a ride across the causeway
and on thorough-fare (Major Collectors) parallel to urban
and rural interstate sections. However, the low traffic
routes were more varied and were selected for
convenience, in consultation with the researchers. All
participants provided written informed consent, and the
study was approved by the State of California Institutional
Review Board, the Committee for the Protection of
Human Subjects.
Exposure measurements
To measure exposure to ultrafine particulate matter
concentrations, a condensation particle counter (CPC)
(TSI Model 3007, TSI, St. Paul, MN, USA) was carried
in a handle bar rack on the researcher’s bike. The par-
ticle counter used a continuous measurement (an inter-
val of 5 s) of the particle number concentration of
ultrafine particles sized down to 10 nm. Because particle
number concentration is dominated by the smallest par-
ticles, this can be considered a measure of UFPM. The
CPC instrument was calibrated by the manufacturer and
a researcher performed flow checks before conducting
the study. The researcher accompanied the study partici-
pants who selected the pacing on each ride. After each
ride, the stored data were downloaded onto the study
computer.
Ambient air pollution (PM2.5, NOX, NO2, NO, and O3)
and meteorological data were obtained from National Air
Monitoring Stations/State and Local Air Monitoring
Stations (NAMS/SLAMS) in the Sacramento and Davis
areas.
Respiratory outcome measurements
Immediately before and after each ride the lung function
of the participants was measured using a portable spir-
ometer (EasyOne Frontline: Medical Technologies
Andover, MA, USA). The results were stored in the
spirometer and downloaded onto the password-protected
computer. Forced vital capacity (FVC), forced expira-
tory volume in one second (FEV1), FEV1/FVC, and peak
expiratory flow rate (PEF) were used as indicators of
lung function outcomes. Also, the pulse rate of the par-
ticipants was recorded before and after each ride using
a pulse oximeter (Onyx 9500 Finger Pulse Oximeter,
NONIN Medical, Inc., Plymouth, MN, USA).
Statistical analyses
The difference in lung function between pre- and post-ride
for each subject was calculated as an outcome variable.
Median concentrations of UFPM exposure (number of
particles/cm3) was used for the main exposure variable
after natural log transformation, and for the purpose of
interpretation of the model results, the IQR of UFPM
exposure concentrations was used to calculate the change
in magnitude for lung function outcomes.
For the first part of the statistical analyses, we compared
the UFPM median concentration by route type (high
traffic vs. low traffic route). The lung function differences
between a high traffic route and a low traffic route by
subject were also compared. If the data were normally
distributed, we used a paired t-test, otherwise, the non-
parametric Wilcoxon Rank-Sum test was used. Addition-
ally, we analyzed the associations between the median
concentration of UFPM exposure during cycling and the
difference in lung function (post-ride level minus baseline
ride level) using mixed models with random effects of
subjects to account for correlation between measurements
from the same participant.
Other covariates including age, sex, body mass index
(BMI), race, average ambient temperature, average hu-
midity during cycling, wind direction (downwind vs.
non-downwind), wind speed, pulse rate difference, average
cycling speed, distance of ride, time of the day for cycling
(morning vs. afternoon), and day of the week (weekdays
vs. weekend) were evaluated. In a multivariate analysis
using linear mixed-effect models, we developed a statis-
tical model with a broad inclusion of all covariates, and
used a 10% change-in-estimate (change > 10%) as the cri-
terion for deciding which confounding factors to exclude
[24]. Covariates selected for the final models were sex,
age, wind direction, and the day of the week.
The SAS statistical package was used for analysis
(Version 9.3, SAS Institute, Cary, NC).
Results
A total of 32 frequent bicyclists participated in the study
(Table 1). The majority of study subjects were male
(75%, n = 24) and non-Hispanic white (91%, n = 29), with
a small percentage of Asian (6%, n = 2), and one partici-
pant that didn’t specify the ethnic information in the
questionnaire. The mean age of the participants was
45.1 years (SD: 12.5 years), and a healthy body weight
was reported for the participants based on BMI (mean:
24.5, SD: 2.4). On average, participants rode 22.2 km
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(13.9 miles) for each trip in this study. Within the group
of study subjects, 4 (13%) subjects reported being former
smokers. Four participants (13%) reported a history of
asthma, and 17 (53%) responded “yes” to a history of
allergies.
Table 2 shows the distribution of UFPM concentra-
tions in number of particles per cubic centimeter
(number of particles/cm3) route type. We observed
that the mean concentrations were nearly three times
higher on the high traffic routes compared to those on
the low traffic routes (49,369 vs. 17,474 in number of
particles/cm3). This difference in average concentration
of UFPM between road types was statistically signifi-
cant (p < 0.0001) with Wilcoxon Rank -Sum test.
We measured lung function before cycling (baseline)
and right after cycling (post) for each ride (Table 3). For
FVC, the average change (post minus baseline) in lung
function for low traffic routes and for high traffic routes
was +0.14 l (SD: 0.31) and −0.12 l (SD: 0.33), respectively,
and these were statistically significant (p = 0.004). Simi-
larly, we found a significant increase of 0.11 l (SD: 0.18) in
FEV1 after rides for low traffic routes (p = 0.002) while a
0.06 l (SD: 0.19) non-significant decrease in FEV1 was ob-
served for high traffic routes. The differences in the effects
of high traffic and low traffic routes on lung function for
FVC and for FEV1 were statistically significant (p = 0.0005
and p = 0.003) respectively from either a Wilcoxon Rank-
Sum test or a paired t-test. There were no statistically sig-
nificant differences in lung function changes between
route types for FEV1/FVC ratio or PEF.
Table 4 shows the parameter estimates of median
UFPM concentrations related to lung function measures
from the final linear mixed-effect model adjusted for the
covariates of age, sex, wind direction, and day of the
week. We observed significant associations between in-
creased levels of median UFPM concentration and de-
creased lung function in FVC and FEV1 (p < 0.01), but
not with FEV1/FVC ratio or PEF. The interpretation of
these significant estimates is that lung function change
(post minus baseline) shifted in the negative direction by
216 mL (3.9%) for FVC and 168 mL (4.1%) for FEV1, re-
spectively, for the IQR increase of median UFPM con-
centration (12,225 to 36,833 number of particles/cm3),
based on parameter estimates shown in Table 4 (β= −0.196,
and β= −0.153, respectively). Regarding other covariates
(data shown in the Additional file 1: Tables S1 and S2),
weekdays compared to weekends as a reference showed sig-
nificant associations (β= −0.343 for FVC, and β= −0.175 for
FEV1) with decreased lung functions. Thus, weekdays com-
pared to weekends might reflect collectively the effects of
other unmeasured pollutants or other factors on lung
functions. Also, we observed a negative trend of down-
wind direction in comparison with non-downwind for
lung function changes, however, it was not statistically
significant (β = −0.065 for FVC, and β = −0.016 for FEV1).
In the final full regression model, sex, age, wind direction
(downwind vs. non-downwind), and the day of the week
(weekdays vs. weekends) were adjusted as confounders.
Discussion
We found a significant association between decreased
lung function and short-term exposure to UFPM mea-
sured during cycling. Previously, Strak et al., reported
positive trends in associations with lung function changes
immediately after cycling, but negative associations six
hours after cycling though none of these results reached
statistical significance [16]. Another study showed that a
decrease in PEF with relation to UFPM exposure was ob-
served right after cycling, however, similar results were
not found with other lung function measurements such as
FVC and FEV1 [19].
In this study, nearly three times higher UFPM con-
centrations were observed in high traffic routes com-
pared to low traffic routes. High traffic routes (e.g., I-80
and I-80B) have high traffic flows, over 100,000 vehicles
per day on average [23], thus, proximity to a high traffic
volume of motor vehicles is reflected by the observed
increase in UFPM concentrations. When compared to
Table 1 Descriptive characteristics of the participants (n = 32)




Race/ethnicity - n (%)
White 29 (91%)
Asian 2 (6%)
Not specified 1 (3%)
Age- Mean (range) 45.1 (23–68), SDa: 12.5
Height (cm) -Mean (range) 175.0 (155.0–196.0), SD: 9.0
Weight (kg) -Mean (range) 75.3 (51.3–108.9), SD: 11.7
BMIb- Mean (range) 24.5 (20.1–29.8), SD: 2.4
Distance for cycling (km)- Mean (range) 22.2 (16.0–32.0), SD: 3.1
Former smokers - n (%) 4.0 (13%)
Ever diagnosed as asthma- n (%) 4.0 (13%)
Ever diagnosed for allergies- n (%) 17.0 (53%)
aSD Standard deviation
bBMI Body weight (kilograms) divided by the square of the body
height (meters)
Table 2 Distribution of UFPM particle number concentration
(in number of particles/cm3) by route type (n = 32)
Road type Mean ± SD Median Range (Min-Max)
High traffic routes 49,369 ± 11,812 44,023 36,049–98,420
Low traffic routes 17,474 ± 6,600 16,553 7,694–25,924
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previously published studies, UFPM concentrations ob-
served in the current study were almost double, and
the bike routes used by cyclists were 2 to 4 times longer
[15, 16, 20, 21]. Thus, the lower level of UFPM exposure
seen in more recently conducted studies and shorter bike
routes might be a reasonable explanation for why these
studies with cyclists did not observe similar significant
reductions in pulmonary function to those seen in our
study. In our study, we observed that lung function
change (post minus baseline) shifted in the negative
direction by 216 mL (3.9%) in FVC and 168 mL (4.1%)
in FEV1 for IQR increase of median UFPM concentra-
tion, and the magnitude of these changes in mL may
represent a small increase in airway resistance.
In addition, the participants in our study used cycling
frequently for active transportation and some of their typ-
ical daily commuting routes included areas along the
major highways and roads in the Sacramento and Davis
regions. Since some of these routes were used in this
study, the study design reflected a real-life situation rather
than scripted exposure designs, used more commonly in
the previously published studies.
There are limitations for this study. First, other air
pollutants during the bicycle rides were not concurrently
measured using a personal exposure monitor. As a crude
proxy for personal exposure of other pollutants, we tested
two pollutant models using ambient air pollution data
from nearby monitoring stations (PM2.5, NOX, NO2, NO,
and O3). The additional co-pollutant modeling approach
did not change the estimates of UFPM concentration on
lung function, and these other pollutants didn’t show sig-
nificant associations. However, considering the fact that
these other pollutants were measured only at monitoring
stations not during bike rides, we cannot make an infer-
ence of these pollutants’ impacts on lung functions per se.
Since our findings do not specifically show a relationship
solely with UFPM exposure, it is still possible that other
pollutants, especially other near roadway traffic and toxic
pollutants as well as other unmeasured factors associated
with traffic, may have contributed to the results of de-
creases in lung function collectively. Although some evi-
dence has suggested that adverse respiratory effects may be
attributable to smaller particles such as UFPM [2, 25, 26],
the source of these health effects from the mixture of
near-roadway emissions remains unidentified.
Asthmatics and smokers can have increased impacts
from traffic exposure; both cases of asthmatics and former
smokers were included in our study. As part of a sensitiv-
ity analysis, we repeated the statistical analyses after ex-
cluding asthmatic cases (n = 4) or former smokers (n = 4),
and similar results were obtained (e.g., β = −0.186 for
FVC, and β = −0.159 for FEV1, respectively). Also, we in-
cluded allergy histories in the final model development,
and it was not statistically significant.
Additionally, airway inflammation is a good biomarker
for respiratory diseases, and certain indicators such as
exhaled nitric oxide (eNO) for airway inflammation can
be informative to confirm lung function symptoms sub-
clinically [27]. Some previous research with healthy cy-
clists showed mixed findings (either negative or positive
associations with eNO) after exposed to air pollutants
such as UFPM during cycling [15, 16], therefore, more re-
search on airway inflammation along with pulmonary
function is warranted.
Apart from air pollution, traffic produces noise which
can influence health as a stressor. Previous studies have
shown that long-term exposure to traffic noise is associ-
ated with an increased risk of diabetes [28] or cardiovas-
cular disease [29]. The current study evaluated the effects
of short-term exposure to UFPM, unlike most of the
noise-related health research which focused on long-term
exposure effects. Hence, the role of noise as a possible
confounder in this study is unclear at this time.
Table 3 aMean and difference of lung function measurements by time of measure and by route type (n = 32)
Outcomes Low traffic routes High traffic routes
Pre-ridea Post-ride Diffb Pre-ride Post-ride Diff
FVC (liters)** 4.74 (0.91) 4.89 (0.96) 0.14 (0.31) 4.86 (0.90) 4.73 (0.99) −0.12 (0.33)
FEV1 (liters)** 3.80 (0.79) 3.91 (0.79) 0.11 (0.18) 3.86 (0.78) 3.81 (0.80) −0.06 (0.19)
FEV1/FVC 0.80 (0.05) 0.80 (0.05) 0.00 (0.04) 0.80 (0.05) 0.81 (0.06) 0.01 (0.04)
PEF (liters/min) 588.57 (119.93) 575.54 (130.93) −13.03 (52.02) 584.83 (123.45) 568.38 (126.71) −16.45 (49.98)
**< 0.005 (significant difference in average lung function measure between low traffic routes and high traffic routes
aMean (SD)
bDiff = Post-ride minus Pre-ride (SD)
Table 4 Regression coefficients† of associations between median
concentrations of UFPM exposure and lung function changes
(post-pre)
Outcomes Estimate 95% Confidence Interval
FVC (liters) −0.196** (−0.314, −0.077)
FEV1 (liters) −0.153*** (−0.221, −0.084)
FEV1/FVC 0.002 (−0.009, 0.013)
PEF (liters/min) −3.103 (−15.390, 9.183)
Regression coefficients of natural log-transformed median concentration of
UFPM exposure after adjusting for age, sex, wind direction (downwind vs.
non-downwind), and day of the week (weekdays vs. weekend) variables
** p < 0.005; *** p < 0.0001
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Conclusions
Our study showed significant associations between in-
creased levels of UFPM concentrations, measured as a
surrogate for short-term exposure of near road traffic
emissions, and decreased lung function after adjusting
for the covariates of age, sex, wind direction, and day of
the week. Previously, the beneficial effects of physical ac-
tivities such as cycling have been shown to outweigh the
risk of air pollution exposure effects or traffic accidents
in modeled analyses [30]. Although further research will
be necessary to evaluate the impacts of chronic traffic-
related UFPM exposure on cyclists, it is reasonable to
assume that adverse impacts from the cumulative effects
of repeated short-term exposures to traffic pollution
may be significant in those that cycle frequently for lon-
ger periods of time. There is also a need for more re-
search to investigate the constituents of traffic pollution
(e.g., UFPM, elemental carbon, brake wear, tire wear,
noise) to determine the factors contributing to its ad-
verse health effects.
Additionally, the majority of the study subjects were
healthy white males, therefore, the generalizability of the
findings to other populations must be interpreted with
caution. Also, larger adverse impacts on lung function
may be more likely in more sensitive populations such
as older individuals or those with more pronounced re-
spiratory conditions.
Overall, our study suggests the need for urban planners
to consider the public health concerns of cyclists and their
exposure to traffic-related air pollution. Reducing traffic
emissions in the environment is critical, particularly on
and near roads where cyclist travel. Research may help to
determine effective mitigation strategies through built en-
vironment designs that reduce cyclist exposure to traffic
pollution and promote safe active transportation. Also, cy-
clists should plan their route to reduce their exposure to
traffic pollution by cycling away from heavily trafficked
roads and highways, where possible.
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Additional file 1: The file contains 2 supplemental tables with full
model specifications referenced in the main manuscript text. Table S1.
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